MDAI Stock Overview An artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Spectral AI, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Spectral AI Historical stock prices Current Share Price US$3.05 52 Week High US$3.72 52 Week Low US$0.82 Beta 0.64 1 Month Change 58.85% 3 Month Change 193.27% 1 Year Change 23.98% 3 Year Change -68.94% 5 Year Change n/a Change since IPO -68.56%
Recent News & Updates
Price target decreased by 7.5% to US$4.93 Dec 20
Investors Still Aren't Entirely Convinced By Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Despite 39% Price Jump Dec 18 Spectral AI, Inc. has filed a Follow-on Equity Offering in the amount of $0.9 million. Dec 13
Spectral AI, Inc. Highlights Unprecedented Collaboration with National Leaders in Burn Care for DeepView™? System Training and Validation Studies
Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision Dec 10 Spectral AI, Inc. has filed a Follow-on Equity Offering in the amount of $0.449694 million. Dec 09
See more updates
Price target decreased by 7.5% to US$4.93 Dec 20
Investors Still Aren't Entirely Convinced By Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Despite 39% Price Jump Dec 18 Spectral AI, Inc. has filed a Follow-on Equity Offering in the amount of $0.9 million. Dec 13
Spectral AI, Inc. Highlights Unprecedented Collaboration with National Leaders in Burn Care for DeepView™? System Training and Validation Studies
Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision Dec 10 Spectral AI, Inc. has filed a Follow-on Equity Offering in the amount of $0.449694 million. Dec 09
Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review Dec 03
New major risk - Share price stability Nov 29
Spectral AI Announces DeepView SnapShot M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research Nov 21 Spectral AI, Inc. has filed a Follow-on Equity Offering in the amount of $2.2701 million. Nov 20
Spectral AI, Inc. has filed a Follow-on Equity Offering in the amount of $2.2701 million. Nov 19
Consensus estimates of losses per share improve by 19% Nov 13
Third quarter 2024 earnings: EPS and revenues exceed analyst expectations Nov 08
New minor risk - Profitability Nov 07
Spectral AI Announces Management Changes for Spectral IP (to be Renamed SIM IP Inc.) Nov 06
Investors Still Aren't Entirely Convinced By Spectral AI, Inc.'s (NASDAQ:MDAI) Revenues Despite 43% Price Jump Nov 03
Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers Oct 30
Spectral AI, Inc. to Report Q3, 2024 Results on Nov 06, 2024 Oct 24 Spectral AI, Inc. Announces Board Changes
Spectral AI, Inc. Completes Proof of Concept for Wound Measurement Technology Oct 03
New minor risk - Share price stability Sep 26
Slammed 25% Spectral AI, Inc. (NASDAQ:MDAI) Screens Well Here But There Might Be A Catch Sep 19
Spectral AI, Inc. Outlines U.S. Regulatory Pathway for Deepview System for Burn Indication Sep 18
Spectral AI, Inc. Completes Burn Center Enrollment for U.S. Burn Pivotal Study Aug 27
New minor risk - Share price stability Aug 15
Analysts Have Been Trimming Their Spectral AI, Inc. (NASDAQ:MDAI) Price Target After Its Latest Report Aug 15
Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Aug 13
Spectral Ai, Inc. Reiterates Revenue Guidance for Fiscal Year 2024 Aug 13
Spectral AI, Inc. Announces Continuing Progress in Development of Handheld Deepview Snapshot M®? for Military Field Use Aug 01
Spectral AI, Inc. to Report Q2, 2024 Results on Aug 12, 2024 Jul 29
Spectral AI, Inc. Adds Three New Clinical Trial Sites to Expedite Emergency Department Patient Enrollment Jul 23
Price target decreased by 8.9% to US$5.65 Jul 16
Spectral AI, Inc. Expands Clinical Trial Sites for Pivotal U.S. Burn Study Jul 04
Spectral Ai Achieves 100% Pediatric Enrollment in Burn Centers for Pivotal U.S. Burn Study Jul 03
Cautious Investors Not Rewarding Spectral AI, Inc.'s (NASDAQ:MDAI) Performance Completely Jun 28 Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study
First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind May 10
Spectral AI, Inc. Reiterates Revenue Guidance for the Year 2024 May 08
Spectral AI, Inc. to Report Q1, 2024 Results on May 07, 2024 Apr 26
Spectral AI, Inc. Appoints Erich Spangenberg CEO of Spectral IP, Its Health Care IP-Focused Subsidiary Apr 25 Spectral AI, Inc., Annual General Meeting, May 14, 2024 Apr 05
Spectral AI, Inc. Announces the Appointment of Jeremiah A. Sparks as Chief Commercialization Officer Apr 02
Full year 2023 earnings: EPS and revenues exceed analyst expectations Mar 31 Spectral AI, Inc. announced that it expects to receive $30 million in funding Mar 21
Spectral AI, Inc. to Report Q4, 2023 Results on Mar 27, 2024 Mar 14
Spectral AI, Inc. Receives UKCA Authorization for Burn Indication Expected Commercialization Second Half 2024 Feb 24
Spectral AI, Inc. Announces Board Changes Feb 13
Spectral AI, Inc. Announces Resignation of Michael Murphy as Director Feb 02
Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI for Burn Injuries Jan 11
Spectral AI, Inc. announced that it expects to receive $10 million in funding from B. Riley Principal Capital II, LLC Dec 28 Spectral AI, Inc. announced that it expects to receive $10 million in funding from B. Riley Principal Capital II, LLC Dec 27
Many Still Looking Away From Spectral AI, Inc. (NASDAQ:MDAI) Dec 27 Spectral AI, Inc. Announces Chief Financial Officer Changes Dec 19
Spectral AI, Inc. Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors Nov 29
Spectral AI, Inc. Appoints Erich Spangenberg as Chairman of the Executive Committee of the Board of Directors Nov 28
Third quarter 2023 earnings released: US$0.77 loss per share (vs US$0.008 loss in 3Q 2022) Nov 17 Spectral AI, Inc. to Report Q3, 2023 Results on Nov 13, 2023 Nov 02
New major risk - Financial position Oct 27 Spectral AI, Inc. Provides Revenue Guidance for Fiscal Year 2024
Spectral AI, Inc. Provides Revenue Guidance for Fiscal Year 2024 Oct 24
Spectral AI's DeepView SnapShot(R) Wound Imaging System, Achieves UKCA Mark and FDA Class 1 Medical Device Classification Oct 20
Spectral Ai, Inc. Adds Additional Clinical Sites to Multi-Center Diabetic Foot Ulcer Study Oct 18
Spectral Ai, Inc. Adds Additional Clinical Sites to Multi-Center Diabetic Foot Ulcer Study Oct 17
Spectral AI, Inc. Appoints Deepak Sadagopan, MHCDS, to Its Board of Directors Oct 05
High number of new and inexperienced directors Sep 13 Shareholder Returns MDAI US Medical Equipment US Market 7D 45.2% 0.8% 0.6% 1Y 24.0% 10.0% 23.7%
See full shareholder returns
Return vs Market: MDAI matched the US Market which returned 23.7% over the past year.
Price Volatility Is MDAI's price volatile compared to industry and market? MDAI volatility MDAI Average Weekly Movement 18.7% Medical Equipment Industry Average Movement 8.0% Market Average Movement 6.3% 10% most volatile stocks in US Market 17.5% 10% least volatile stocks in US Market 3.1%
Stable Share Price: MDAI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MDAI's weekly volatility (19%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals.
Show more Spectral AI, Inc. Fundamentals Summary How do Spectral AI's earnings and revenue compare to its market cap? MDAI fundamental statistics Market cap US$53.65m Earnings (TTM ) -US$11.12m Revenue (TTM ) US$27.26m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) MDAI income statement (TTM ) Revenue US$27.26m Cost of Revenue US$14.90m Gross Profit US$12.36m Other Expenses US$23.48m Earnings -US$11.12m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.57 Gross Margin 45.34% Net Profit Margin -40.78% Debt/Equity Ratio -137.8%
How did MDAI perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/30 00:40 End of Day Share Price 2024/12/30 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Spectral AI, Inc. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Michael Gorman BTIG Swayampakula Ramakanth H.C. Wainwright & Co. Carl Byrnes Northland Capital Markets
Show 5 more analysts 
